Overview
- NB.1.8.1, nicknamed Nimbus, accounted for 37% of US COVID-19 diagnoses from May 25 to June 7, making it the second-most common strain after Omicron LP.8.1.
- Clinicians describe a distinctive “razor throat” characterized by a sharp, stabbing sore throat often paired with fatigue, mild cough, fever, muscle aches and occasional digestive issues.
- The World Health Organization classified Nimbus as a “variant under monitoring” in May following its January emergence in China and has since reported its presence in at least 22 countries.
- Data from the UK Health Security Agency show COVID-related hospital admissions in the UK rose nearly 10% in the week ending May 31 as Nimbus’s share of cases climbed.
- Preliminary evidence indicates Nimbus does not cause more severe illness than previous variants, reinforcing current public health guidance.